Literature DB >> 3367426

Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications.

M Y Kuo1, J Goldberg, L Coates, W Mason, J Gerin, J Taylor.   

Abstract

cDNA prepared from the single-stranded circular RNA genome of hepatitis delta virus was cloned in lambda gt11 by using RNA from the liver of an infected woodchuck. From the sequence of overlapping clones, we assembled the full sequence of 1,679 nucleotides. The sequence indicated an exceptional ability for intramolecular base pairing, yielding a rod structure with at least 70% of the bases paired and a predicted free energy of -805 kcal (-3,368 kJ)/mol. Three of the lambda clones contained sequences that were not only expressed as fusion proteins with beta-galactosidase but were recognized by human hepatitis delta virus-specific antibody. These clones were sequenced so as to establish the reading frame of the delta antigen on the antigenomic strand. The fusion protein produced by one clone was purified by immunoaffinity chromatography and then was used to raise rabbit antibodies specific for the delta antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367426      PMCID: PMC253266     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Inability of circular mRNA to attach to eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Nature       Date:  1979-07-05       Impact factor: 49.962

2.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

3.  India ink staining of proteins on nitrocellulose paper.

Authors:  K Hancock; V C Tsang
Journal:  Anal Biochem       Date:  1983-08       Impact factor: 3.365

4.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

7.  Delta hepatitis agent: structural and antigenic properties of the delta-associated particle.

Authors:  F Bonino; B Hoyer; J W Shih; M Rizzetto; R H Purcell; J L Gerin
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Yeast RNA polymerase II genes: isolation with antibody probes.

Authors:  R A Young; R W Davis
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  119 in total

1.  Characterization of the 5' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus.

Authors:  S Gudima; K Dingle; T T Wu; G Moraleda; J Taylor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs.

Authors:  C E Reid; D W Lazinski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Efficient site-specific nonribozyme opening of hepatitis delta virus genomic RNA in infected livers.

Authors:  J Chang; G Moraleda; S Gudima; J Taylor
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Prominent polypurine and polypyrimidine tracts in plant viroids and in RNA of the human hepatitis delta agent.

Authors:  A D Branch; S E Lee; O D Neel; H D Robertson
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

10.  Introduction of hepatitis delta virus into animal cell lines via cationic liposomes.

Authors:  V Bichko; H J Netter; J Taylor
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.